Powerful Psychedelic Drug Gains New Notice as an Opioid Addiction Therapynews2024-03-05T18:32:51+00:00March 5th, 2024|The New York Times|
More Young People Are on Multiple Psychiatric Drugs, Study Findsnews2024-02-16T17:25:11+00:00February 16th, 2024|The New York Times|
Use of ADHD Drugs Surged During Pandemic, Study Findsnews2024-01-10T17:25:09+00:00January 10th, 2024|The New York Times|
Bristol Myers to Acquire the Drugmaker Karuna for $14 Billionnews2023-12-22T17:55:31+00:00December 22nd, 2023|The New York Times|
What to Know About the Effects of Ketaminenews2023-12-16T16:55:07+00:00December 16th, 2023|The New York Times|
Psychedelic Mushrooms Hit the Market in Oregonnews2023-10-23T09:01:31+00:00October 23rd, 2023|The New York Times|
FDA Issues Warning Over Misuse of Ketamine Therapynews2023-10-11T20:50:31+00:00October 11th, 2023|The New York Times|
A Clash of Views Over the Israel-Hamas Warnews2023-10-09T18:04:27+00:00October 9th, 2023|The New York Times|
The A.D.H.D. Drug Shortage Is Causing Real Painnews2023-10-09T09:00:47+00:00October 9th, 2023|The New York Times|
